Video

Focusing on Improving Depression in HNC Survivors

As cancer survivors are living longer thanks to new treatments, it is essential that health care providers and researchers put more focus on depression.

Now that patients with head and neck cancer (HNC) — as well as many other cancer types – are living much longer, it is essential that researchers and health care professionals recognize the importance of depression and quality-of-life issues, according to Nosayaba Osazuwa-Peters, BDS, MPH, CHES, Instructor, Department of Otolaryngology-Head and Neck Surgery, Saint Louis University School of Medicine.

Osazuwa-Peters’ recent research shed light on suicide rates in HNC survivors, which he noted were on the rise for all cancer types. Many suicide risk factors, such as depression and pain, are common in survivors, so it is imperative that signs of suicide are recognized in this population so individuals can get the help that they may need.

Related Videos
Dr. Michael Bogenschutz
Photo credit: Max Mumby/Indigo via Getty Images
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Stephanie Alice Baker
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
Dr. Richard “Rick" Winneker
Related Content